Nidan Laboratories And Healthcare Limited (NSE: NIDAN) is a Palghar, Maharashtra-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹18 Cr, it ranks #4,489 by market cap among the 6,197 Indian listed companies on FinBizNet, and #13 of 18 in Medical Diagnostic Centres. At ₹12.95 (as of 16 Nov 2026), the share price is 48.0% below its 52-week high of ₹24.90 and 12.6% above its 52-week low of ₹11.50. The share price is down 29.9% over one year and up 6.2% over three months.
| Current Price | ₹12.95 |
|---|---|
| Market Cap | ₹18 Cr |
| NSE Symbol | NIDAN |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 12 |
| Return on Equity | 2.19% |
| Return on Assets | 2.22% |
| 52-Week Range | ₹11.50 – ₹24.90 |
| 1-Year Price Change | -29.9% |
| 3-Month Price Change | +6.2% |
| Beta (1Y) | 0.27 |
| Headquarters | Palghar, Maharashtra |
| Website | www.nidanhealthcare.co.in |
Promoters held 57.04% of Nidan Laboratories And Healthcare Limited's shares as of Jun 2026, unchanged from Mar 2025.
Nidan Laboratories and Healthcare Limited provides healthcare and diagnostic services in India. It offers diagnostic services, including pathology, radiology, cardiology, and neurology services. The company was founded in 1994 and is headquartered in Palghar, India.
1. Diagnostic Centre-This segment operates in the diagnostic centre business.
1. Diagnostic Centre-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Dr. Lal Pathlabs Ltd | ₹33,934 Cr | 66.4 | 21.48% | ₹874 Cr | +28.7% |
| Vijaya Diagnostic Centre Limited | ₹14,665 Cr | 84.3 | 19.70% | ₹255 Cr | +38.5% |
| Metropolis Healthcare Limited | ₹11,952 Cr | 61.5 | 13.37% | ₹497 Cr | +14.9% |
| Throcare Technologies Ltd | ₹7,764 Cr | 47.6 | 28.74% | ₹271 Cr | +7.5% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,856 Cr | 55.4 | 13.84% | ₹99 Cr | +6.9% |
| Krsnaa Diagnostics Ltd | ₹1,625 Cr | 16.8 | 10.89% | ₹271 Cr | -27.0% |
| Gaudium IVF and Women Health Limited | ₹803 Cr | 27.4 | 16.08% | ₹37 Cr | — |
| Chandan Healthcare Limited | ₹582 Cr | 21.9 | 18.43% | ₹81 Cr | — |
| Nidan Laboratories And Healthcare Limited | ₹18 Cr | 12 | 2.19% | — | -29.9% |
Listed by market capitalisation. Ratios are shown for context only.
Nidan Laboratories And Healthcare Limited is trading at ₹12.95, with a market capitalisation of ₹18 Cr.
Nidan Laboratories And Healthcare Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Nidan Laboratories And Healthcare Limited has a P/E of 12 and a return on equity of 2.19%.
Nidan Laboratories And Healthcare Limited is listed on the NSE under the symbol NIDAN.
Nidan Laboratories And Healthcare Limited's share price is down 29.9% over one year and up 6.2% over three months. Its 52-week range is ₹11.50 to ₹24.90.
Promoters held 57.04% of Nidan Laboratories And Healthcare Limited's shares as of Jun 2026, unchanged from Mar 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.